Duration of Smoking Cessation and Postoperative Morbidity After Esophagectomy for Esophageal Cancer: How Long Should Patients Stop Smoking Before Surgery?

World Journal of Surgery
Naoya YoshidaHideo Baba

Abstract

Smoking is one of the risk factors for postoperative morbidity. There were no studies on the correlation between the duration of smoking cessation and the incidence of morbidities after esophagectomy. A total of 246 patients undergoing elective esophagectomy with 2- or 3-field lymphadenectomy for esophageal cancer between April 2005 and February 2015 were retrospectively analyzed. Patients were divided into five groups according to the duration of smoking cessation [no smoking cessation (including cessation for a few days), cessation for 7-30, 31-90, ≥91 days, never smoker]. Any morbidity of Clavien-Dindo classification (CDc) ≥II, pneumonia, any pulmonary morbidity, surgical site infection, cardiovascular morbidity, and severe morbidities of CDc ≥IIIb frequently occurred in patients with no smoking cessation. The incidence of pneumonia and severe morbidities decreased as the duration of smoking cessation became longer. Logistic regression analysis suggested that no smoking cessation was the independent risk factor for any pulmonary morbidity (HR 3.68, 95% CI 1.152-11.74; p = 0.028). Smoking cessation ≤30 days was also the independent risk factor for pneumonia (HR 2.89, 95% CI 1.141-7.301; p = 0.025). Smoking cessation ≤90 days ...Continue Reading

References

Mar 5, 2009·The Journal of Thoracic and Cardiovascular Surgery·Cameron D WrightUNKNOWN Society of Thoracic Surgeons General Thoracic Surgery Database
Aug 25, 2010·The Annals of Thoracic Surgery·Brechtje A GrotenhuisJ Jan B van Lanschot
Sep 9, 2010·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Birat DhungelJames P Dolan
Dec 25, 2010·Annals of Surgical Oncology·Urs ZinggDavid I Watson
Mar 23, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·M K FergusonV Prachand
Apr 29, 2011·The Annals of Thoracic Surgery·Mark K FergusonVivek Prachand
Jan 17, 2012·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·C SchiemanM S Allen
Jun 1, 2012·The New England Journal of Medicine·P van HagenUNKNOWN CROSS Group
Jul 5, 2012·Interactive Cardiovascular and Thoracic Surgery·Amir H SepehripourAlex R Shipolini
Nov 6, 2013·The Journal of Thoracic and Cardiovascular Surgery·Umberto BenedettoUNKNOWN Harefield Cardiac Outcomes Research Group
Nov 21, 2013·Annals of Surgery·John M FindlayNicholas D Maynard
Jul 9, 2014·World Journal of Surgery·Styliani MantziariMarkus Schäfer

❮ Previous
Next ❯

Citations

Dec 9, 2017·Diseases of the Colon and Rectum·Vladimir BolshinskyAlexander Heriot
Oct 13, 2017·European Journal of Anaesthesiology·Alparslan TuranJacek B Cywinski
Sep 17, 2020·Annals of the New York Academy of Sciences·Mickael ChevallayStefan Mönig
May 16, 2018·Annals of the New York Academy of Sciences·Alicia S BorggreveLucas Goense
Jun 29, 2018·Esophagus : Official Journal of the Japan Esophageal Society·Takeharu ImaiYasuhiro Shimizu
Oct 3, 2020·Annals of Gastroenterological Surgery·Naoya YoshidaHideo Baba
Jul 12, 2020·Langenbeck's Archives of Surgery·Diana Vetter, Christian A Gutschow
Jun 13, 2018·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·N YoshidaH Baba
Nov 7, 2017·AORN Journal·Carol A Devlin, Suzanne C Smeltzer
Jun 27, 2020·Journal of the American Association of Nurse Practitioners·Rony Boe, Stanley Lee Ridner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.